A Six-Domain Brief PID-5 for Primary Care: Validating the PID5BF+M
- Instrument and sample. The modified Brief Personality Inventory for DSM-5 (PID5BF+M) is a 36-item self-report measure covering six maladaptive trait domains – negative affectivity, detachment, antagonism, disinhibition, psychoticism, and anankastia – the standard DSM-5 Section III set plus the ICD-11-aligned anankastia domain. It was validated in N = 1,030 German primary-care patients and benchmarked against a representative general-population sample (N = 4,172).
- Factor structure. Confirmatory factor analysis supported the hypothesised six-domain structure with good fit: CFI = 0.949, TLI = 0.942, RMSEA = 0.044, SRMR = 0.058. The model held in a treatment-seeking, non-specialist population, where comorbidity and symptom load typically blur trait boundaries.
- Reliability and convergent validity. Internal consistency was adequate across all six domain scales (McDonald's ω = 0.75–0.85). Total and domain scores – most strongly negative affectivity – correlated positively with depression (PHQ-9), anxiety (GAD-7), and somatic symptom burden (PHQ-15), supporting convergent validity with routine transdiagnostic screeners already used in primary care.
- Discriminant signal. Primary-care patients scored lower on maladaptive traits than the general-population reference sample after regression adjustment – a counterintuitive but interpretable result that the authors attribute to help-seeking and sampling characteristics rather than to instrument failure.
The clinical case for the PID5BF+M rests less on novelty than on placement. The dimensional trait model of personality pathology – domains and facets rather than categorical disorders – has strong evidence behind it, but its full instruments are long, and personality assessment has remained largely confined to specialist settings. Most patients with personality difficulty, however, never reach a specialist. They present to a general practitioner with low mood, diffuse anxiety, or unexplained physical complaints, and the underlying trait structure goes unmeasured. A 36-item form that holds its factor structure in exactly that population is therefore a meaningful addition to the screening toolkit.
The convergent pattern is the practically useful part. Negative affectivity tracking PHQ-9 and GAD-7 means the domain a clinician is most likely to detect informally is also the one the scale captures most reliably. But the incremental value lies in what symptom screeners miss: detachment, antagonism, disinhibition, and anankastia are not measured by PHQ-9 or GAD-7 at all, yet they shape engagement, adherence, and the therapeutic relationship. A patient whose depression sits atop high detachment or marked anankastia requires a different stance than one without – and the brief form surfaces that distinction without a structured interview.
The inclusion of anankastia deserves emphasis. The original DSM-5 Section III scheme omitted a compulsivity domain; the ICD-11 personality model restored it. The PID5BF+M operationalises the convergence of the two systems, which matters for any clinician working across diagnostic frameworks or anticipating the ICD-11 transition.
Two cautions temper the enthusiasm. First, this is a screening instrument, not a diagnostic one: elevated domain scores flag a profile worth exploring, not a personality disorder. Second, the lower trait scores in primary care relative to the general population are a reminder that brief self-report in a help-seeking sample carries its own response dynamics – patients consulting for an acute concern may under-endorse stable trait items, and base rates differ from those in specialist or community samples. Cut-offs validated elsewhere should not be transported uncritically.
For routine practice, the appeal is workflow. The form sits alongside the PHQ-9 and GAD-7 a clinician already administers, adds the trait dimension those scales cannot reach, and returns a six-domain profile in minutes. That is the threshold at which dimensional personality assessment becomes feasible outside the specialist clinic – which is where most of the relevant patients are.
Where it fits in the assessment stack
The PID5BF+M is best read as a triage layer, not a substitute for the full PID-5 or a clinical interview. Its role is to decide who warrants deeper trait assessment and to give the generalist a structured vocabulary for a domain usually handled by intuition.
What still needs testing
Test-retest stability, predictive validity for treatment response, and cross-cultural invariance beyond the German validation remain open. Until cut-offs are anchored in the local population, the instrument is most defensible as a profile generator rather than a case-finding gate.
Symptom screeners catch the distress; the trait form catches the structure underneath it – and in primary care, the structure is usually what goes unmeasured.
Cross-sectional design; no test-retest data reported; single-country (German) validation limits cross-cultural generalisability; the lower trait scores in primary care versus the general population suggest sampling and response effects that complicate cut-off transport; convergent validity established against symptom screeners rather than against a gold-standard structured personality interview.